The influence of two distinct alloresponse pathways on the design of peptide-based strategies for allograft tolerance

Research in Immunology

Volumn 147, Issue 6, 1996, Pages 377-387

  Benichou, G ^a   Tam, R C ^a   Soares, L R B ^a   Popov, I A ^a   Garovoy, M R ^a   Fedoseyeva, E V ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

T LYMPHOCYTE RECEPTOR;

ANTIGEN PRESENTATION; GRAFT REJECTION; HUMAN; IMMUNOLOGICAL TOLERANCE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0029790010     PISSN: 09232494     EISSN: None     Source Type: Journal    
DOI: 10.1016/0923-2494(96)82046-3     Document Type: Article

References (50)

1. Arnold, B., Messerle, M., Jatsch, L., Kublbeck, G. & Koszinowski, U. (1990), Transgenic mice expressing a soluble foreign H-2 class I antigen are tolerant to allogeneic fragments presented by self class I but not to the whole membrane-bound alloantigen. Proc. Natl. Acad. Sci. USA, 87, 1762-1766.
2. Ashwell, J.D., Chen, C. & Schwartz, R.H. (1986), High frequency and nonrandom distribution of alloreactivity in T cell clones selected for recognition of foreign antigen in association with self class II molecules. J. Immunol., 136, 389-395.
3. Auchincloss, H.J., Lee, R., Shea, S., Markowitz, J.S., Grusby, M.J. & Glimcher, L.H. (1993), The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class-II-deficient mice. Proc. Natl. Acad. Sci. USA, 90, 3373-3377.
4. Benichou, G., Takizawa, A.P., Olson, A.C., McMillan, M. & Sercarz, E.E. (1992), Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection. J. Exp. Med., 175, 305-308.
5. Benichou, G., Fedoseyeva, E., Lehmann, P.V., Olson, C.A., Geysen, H.M., McMillan, M. & Sercarz, E.E. (1994), Limited T cell response to donor MHC peptides during allograft rejection. Implications for selective immune therapy in transplantation. J. Immunol., 153, 938-946.
6. Bill, J., Yague, J., Appel, V.B., White, J., Horn, G., Erlich, H.A. & Palmer, E. (1989), Molecular genetic analysis of 178 I-A bm-12-reactive T cells. J. Exp. Med., 169, 115-133.
7. Billingham, R.E., Brent, L. & Medawar, P.B. (1953), Actively acquired tolerance of foreign cells. Nature (Lond.), 172, 603-606.
8. Botazzo, G.F., Pujol-Borrell, R., Hanafusa, T. & Feldmann, M. (1983), Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet, 2, 1115-1119.
9. + T-cell dependent antibody-mediated graft rejection. Immunol. Today, 13, 434-438.
10. Buelow, R., Burlingham, W.J. & Clayberger, C. (1995), Immunomodulation by soluble HLA class I. Transplantation, 59, 649-654.
11. Charlton, R.K. & Zmijewski, C.M. (1970), Soluble HLA-A7 antigen: localization in the beta-lipoprotein fraction of human serum. Science, 170, 636-637.
12. Chen, B.P., Madrigal, A. & Parham, P. (1990), Cytotoxic T cell recognition of an endogenous class I HLA peptide presented by a class II HLA molecule. J. Exp. Med., 172, 779-788.
13. Clayberger, C., Parham, P., Rothbard, J., Ludwig, D.S., Schoolnik, G.K. & Krensky, A.M. (1987), HLA-A2 peptides can regulate cytolysis by human allogeneic T lymphocytes. Nature (Lond.), 330, 763-765.
14. Dausset, J. (1981), The major histocompatibility complex in man. Science, 213, 1469-1474.
15. De Koster, H.S., Anderson, D.C. & Termijtelen, A. (1989), T cells sensitized to synthetic HLA-DR3 peptide give evidence of continuous presentation of denatured HLA-DR3 molecules by HLA-DP. J. Exp. Med., 169, 1191-1196.
16. + alloreactive T lymphocyte clone. J. Exp. Med., 172, 387-390.
17. Fangmann, J., Dalchau, R., Sawyer, G.J., Priestly, C.A. & Fabre, J.W. (1992), T cell recognition of donor major histocompatibility complex class I peptides during allograft rejection. Eur. J. Immunol., 22, 1525-1529.
18. Gaspari, A.A., Jenkins, M.K. & Kaltz, S.I. (1988), Class II MHC-bearing keratinocytes induce antigen-specific unresponsiveness in hapten-specific TH1 clones. J. Immunol., 1, 2216-2220.
19. Hart, D.N.J., Winearls, C.G. & fabre, J.W. (1980), Graft adaptation: studies on possible mechanisms in long-term surviving rat renal allografts. Transplantation, 30, 73-80.
20. Hayry, P., VonWillebrand, E., Partehnais, E., Nemlander, A., Soots, A., Lautenschlager, I., Alfoldy, P. & Renkonen, R. (1984), The inflammatory mechanisms of allograft rejection. Immunol. Rev., 77, 85-142.
21. Heath, W.R. & Sherman, L.A. (1990), Cell type-specific recognition of allogeneic cells by alloreactive cytotoxic T cells: consequence of peptide-dependent allorecognition. Eur. J. Immunol., 21, 153-159.
22. Heath, W.R., Hurd, M.E., Carbone, F.R. & Sherman, L.A. (1989), Peptide-dependent recognition of H-2K by alloreactive cytotoxic T lymphocytes. Nature (Lond.), 341, 749-752.
23. Heath, W.R., Kane, K.P., Mescher, M.F. & Sherman, L.A. (1991), Alloreactive T cells discriminate among a diverse set of endogenous peptides. Proc. Natl. Acad. Sci. USA, 88, 5101-5105.
24. Lechler, R.I., Heaton, T., Barber, L., Bal, V., Batchelor, J.R. & Lombardi, G. (1992), Molecular mimicry by major histocompatibility complex molecules and peptides accounts for some alloresponses. Immunol. Lett., 34, 63-69.
25. Lechler, R.I. & Batchelor, J.R. (1982), Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells. J. Exp. Med., 155, 31-41.
26. Lindahl, K.F. & Wilson, D.B. (1977), Histocompatibility antigen-activated cytotoxic T lymphocytes. - II. Estimates of the frequency and specificity of precursors. J. Exp. Med., 145, 508-522.
27. Liu, Z., Braunstein, N.S. & Suciu-Foca, N. (1992), T cell recognition of allopeptides in the context of syngeneic MHC. J. Immunol., 148, 35-40.
28. Liu, Z., Sun, Y.K. & Xi, Y.P. (1993), Limited usage of T cell receptor V beta genes by allopeptide-specific T cells. J. Immunol., 150, 3180-3186.
29. Lo, D., Burkly, L.C., Flavell, R.A., Palmiter, R.D. & Brinster, R.L. (1989), Tolerance in transgenic mice expressing class II major histocompatibility complex on pancreatic acinar cells. J. Exp. Med., 170, 87-104.
30. Lombardi, G., Sidhu, S., Batchelor, J.R. & Lechler, R.I. (1989a), Allorecognition of DR1 by T cells from a DR4/DRw 13 responder mimics self-restricted recognition of endogenous peptides. Proc. Natl. Acad. Sci. USA, 86, 4190-4194.
31. Lombardi, G., Sidhu, S., Lamb, J.R., Batchelor, J.R. & Lechler, R.I. (1989b), Co-recognition of endogenous antigens with HLA-DR1 by alloreactive T cell clones. J. Immunol., 142, 753-759.
32. Maryanski, J.L., Pala, P., Corradin, G., Jordan, B.R. & Cerottini, J.C. (1986), H-2-restricted cytolytic T cells specific for HLA can recognize a synthetic HLA peptide. Nature (Lond.), 324, 578-579.
33. Matzinger, P. & Bevan, M.J. (1977), Hypothesis: why do so many lymphocytes respond to major histocompatibility antigens. Cell. Immunol., 29, 1-5.
34. + T cells recognize H-2Ld class I determinants in the context of class II MHC molecules. J. Immunol., 147, 2868-2874.
35. Mizuochi, T., Ono, S., Malek, T.R. & Singer, A. (1986), Characterization of two distinct primary T cell populations that secrete interleukin-2 upon recognition of class I and class II major histocompatibility antigens. J. Exp. Med., 163, 603-619.
36. Nisco, S., Vriens, P., Hoyt, G., Lyu, S-C., Farfan, F., Pouletty, P., Krensky, A.M. & Clayberger, C. (1994), Induction of allograft tolerance in rats by an HLA class-I-derived peptide and cyclosporine A. J. Immunol., 152, 3786-3792.
37. Nobner, E., Goldberg, J.E., Naftzger, C., Lyu, S-C., Clayberger, C. & Krensky, A.M. (1996), HLA-derived peptides which inhibit T cell function bind to members of the heat-shock protein 70 family. J. Exp. Med., 183, 339-348.
38. Olson, C.A., Williams, L.C., McLaughlin-Taylor, E. & McMillan, M. (1989), Creation of H-2 class I epitopes using synthetic peptides: recognition by alloreactive cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. USA, 86, 1031-1035.
39. Parham, P., Clayberger, C., Zorn, S.L., Ludwig, D.S., Schoolnik, G.K. & Krensky, A.M. (1987), Inhibition of alloreactive cytotoxic T lymphocytes by peptides from the alpha-2 domain of HLA-A2. Nature (Lond.), 325, 625-628.
40. + cytotoxic T cells directed to donor MHC class I peptides following mouse allotransplantation. Transplantation, 60, 1621-1624.
41. Sawyer, G.J., Dalchau, R. & Fabre, J.W. (1993), Indirect T cell allorecognition: a cyclosporin A resistant pathway for T cell help for antibody production to donor MHC antigens. Transplant. Immunol., 1, 77-81.
42. Sayegh, M.H., Khoury, S.K., Hancock, W.W., Weiner, H.L. & Carpenter, C.B. (1992), Induction of immunity and oral tolerance with polymorphic class II MHC allopeptides in the rat. Proc. Natl. Acad. Sci. USA, 89, 7762, 7766.
43. Sayegh, M.H., Perico, N., Imberti, O., Hancock, W.W., Carpenter, C.B. & Remuzzi, G. (1993), Thymic recognition of class II MHC allopeptides induces donor specific unresponsiveness to renal allografts. Transplantation, 56, 461-465.
44. Sherwood, R.A., Brent, L. and Rayfield, L.S. (1986), Presentation of alloantigens by host cells. Eur. J. Immunol., 16, 569-574.
45. Sloan-Lancaster, J. and Allen, P.M. (1995), Significance of T-cell stimulation by altered peptide ligands in T cell biology. Curr. Top. Immunol., 7, 103-109.
46. Snell, G.D. (1981), Studies in histocompatibility. Science, 213, 172-178.
47. Song, E.S., Linsk, R., Olson, C.A., McMillan, M. and Goodenow, R.S. (1988), Allospecific cytotoxic T lymphocytes recognize an H-2 peptide in the context of a murine major histocompatibility complex class I molecule. Proc. Natl. Acad. Sci. USA, 85, 1927-1931.
48. Spencer, S.C. and Fabre, J.W. (1987), Bulk purification of a naturally occuring soluble form of RT1-A class I major histocompatibility complex antigens from DA rat liver, and studies of specific immunosuppression. Transplantation, 44, 141-148.
49. Tam, R.C., Fedoseyeva, E.V., Moskalenko, M., Garovoy, M.R. and Benichou, G. (1996), T cell tolerance is influenced by concomitant recognition of crossreactive self-peptides. J. Immunol., 156, 3765-3771.
50. Van Rood, J.J., Van Leeuwen, A. and Santen, M.C.T. (1970), Anti-HLA-A2 inhibitor in normal serum. Nature (Lond.), 226, 366-367.